SPDR S&P Biotech ETF Newsroom

Oppenheimer's One Buy Vs. One Sell Idea From Each SMID Sector

Seeking AlphaOct 28 23:57

Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today

BenzingaOct 28 23:00

Sweetgreen, Tesla, Digital Realty Trust And A Health Care Stock On CNBC's 'Final Trades'

BenzingaOct 28 20:43

AbbVie to Buy Aliada Therapeutics for $1.4B in Cash

Seeking AlphaOct 28 20:14

About 75% of Companies That Reported Earnings This Week Delivered EPS Wins-Earnings Scorecard

Seeking AlphaOct 27 01:46

Forecasting The Future: 11 Analyst Projections For AbbVie

BenzingaOct 26 05:01

AbbVie Analyst Ratings

BenzingaOct 26 02:22 · Ratings

IDEAYA Reports Phase 1 Expansion Data for IDE397

Seeking AlphaOct 25 23:09

Check Out What Whales Are Doing With ABBV

BenzingaOct 25 02:00

3 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaOct 25 00:37

Peering Into Insmed's Recent Short Interest

BenzingaOct 25 00:18

UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday

BenzingaOct 24 23:03

Market-Moving News for October 24th

BenzingaOct 24 20:10

Viking Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results.

BenzingaOct 24 19:57

Viking Therapeutics GAAP EPS of -$0.22 Beats by $0.03

Seeking AlphaOct 24 04:14

$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

BenzingaOct 24 03:30

Incyte Analyst Ratings

BenzingaOct 24 01:11 · Ratings

Here Are the Major Earnings After the Close Today

Seeking AlphaOct 23 22:00

An Overview of Viking Therapeutics's Earnings

BenzingaOct 23 02:02

Market Whales and Their Recent Bets on VKTX Options

BenzingaOct 23 00:15